In focus · trending topic

Axiomer

8 stories · following the connections

ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB

By Nasdaq OMXApr 30, 2018, 11:00 AM UTC

ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology

By Nasdaq OMXApr 10, 2018, 11:00 AM UTC

ProQR to Present at Upcoming Scientific Meeting and Investor Conference

By Nasdaq OMXFeb 6, 2018, 12:00 PM UTC

ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology

By Nasdaq OMXJan 8, 2018, 12:01 PM UTC

ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference

By Nasdaq OMXOct 24, 2017, 11:00 AM UTC

ProQR to Present at the Chardan Inaugural Gene Therapy Conference

By Nasdaq OMXOct 6, 2017, 11:00 AM UTC

ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology

By Nasdaq OMXSep 21, 2017, 11:05 AM UTC

ProQR Strengthens its Scientific Advisory Board with the Appointment of Dr. Phil Zamore, Dr. Cy Stein and Dr. Scott Armstrong

By Nasdaq OMXAug 28, 2017, 11:00 AM UTC